Trial intelligence / Profile preview

Clonidine versus placebo before stereotactic surgery for hemodynamics and sedation

IRCT20210614051574N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of clonidine in brain neoplasm (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure and Sedation. Started Aug 2021; status: completed.

02

Drugs

clonidine
03

Conditions

brain neoplasm

Beyond the preview

Go deeper on IRCT20210614051574N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210614051574N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call